title: Oral fluid testing: promises and pitfalls.
authors.affiliation: Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA. mhuestis@intra.nida.nih.gov
authors.forename: Marilyn A
authors.initials: MA
authors.lastname: Huestis
authors.forename: Alain
authors.initials: A
authors.lastname: Verstraete
authors.forename: Tai C
authors.initials: TC
authors.lastname: Kwong
authors.forename: Jorg
authors.initials: J
authors.lastname: Morland
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Vincent
authors.forename: Raphael
authors.initials: R
authors.lastname: de la Torre
mesh_terms: D000700:Analgesics / Q000032:analysis; D001334:Automobile Driving; D002853:Chromatography, Liquid; D013759:Dronabinol / Q000031:analogs & derivatives / Q000032:analysis; D006801:Humans; D007118:Immunoassay / Q000379:methods; D002189:Marijuana Abuse / Q000175:diagnosis; D010146:Pain / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000032:analysis; D012463:Saliva / Q000737:chemistry*; D015813:Substance Abuse Detection / Q000331:legislation & jurisprudence / Q000379:methods*; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000188:drug therapy; D053719:Tandem Mass Spectrometry; D017132:Workplace
chemical_list: D000700:Analgesics; D011619:Psychotropic Drugs; C016780:11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid; D013759:Dronabinol